Description and mission evaluation of the Hungarian case‐control surveillance of congenital abnormalities, 1980–1996

Abstract

This system is appropriate for postmarketing the surveillance of drug teratogenicity, for the improvement of congenital abnormality diagnosis, to get informed consent, to have a communication with parents and to provide material for research.